VTR News Alert Ventas Inc (VTR) 71.73 12/25/2014 15:48:43

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ventas Inc (VTR) 71.73 $VTR

Healthcare REITs Risk Report: Caution Merited
Morgan Myrmo - at Seeking Alpha - Wed Dec 24, 3:01PM CST

SPY: 207.77 (+0.02), HCP: 44.00 (-0.45), CLDT: 29.30 (+0.20), HCN: 76.10 (-0.58), CPT: 75.44 (-0.56), APTS: 8.90 (-0.02), IYR: 77.48 (-1.13), O: 49.42 (+0.33), VTR: 71.73 (-0.89), MAA: 76.00 (-0.21)

Brad Thomas Positions For 2015: Attractive Opportunities Present Themselves In REITs
Brad Thomas - at Seeking Alpha - Tue Dec 23, 11:00AM CST

ROIC: 16.92 (+0.03), AVIV: 34.73 (-0.05), HCP: 44.00 (-0.45), HCN: 76.10 (-0.58), UHT: 48.41 (-0.04), DLR: 66.13 (-0.21), SBRA: 30.25 (-0.06), BT: 64.37 (+0.17), HR: 27.54 (-0.02), VTR: 71.73 (-0.89), SNH: 22.07 (+0.04), CCG: 7.58 (-0.05), CTRE: 12.23 (-0.03), OHI: 39.38 (-0.05), ARCP: 8.33 (unch), NHI: 70.18 (-0.03), LTC: 42.71 (+0.05), SA: 7.03 (+0.22), HTA: 26.78 (-0.21)

CorEnergy Is Substantially Undervalued With Upside Of 75% And An 8.5% Yield
Dane Bowler - at Seeking Alpha - Tue Dec 23, 4:00AM CST

UPL: 13.32 (-0.49), NNN: 40.27 (+0.15), O: 49.42 (+0.33), WSR: 15.05 (+0.06), AEE: 46.84 (+1.21), CORR: 6.34 (+0.05), VTR: 71.73 (-0.89), LG: 52.97 (+0.51)

A 4% Dividend Yield Portfolio: A Post Mortem After A Wild Month
Ron Honig - at Seeking Alpha - Tue Dec 23, 2:29AM CST

HCP: 44.00 (-0.45), ETN: 69.30 (-0.09), CBRL: 138.16 (+0.46), AVA: 35.84 (+0.66), UL: 41.49 (+0.09), CVX: 113.47 (-0.48), WEC: 53.56 (+1.08), BBL: 42.86 (-0.19), VTR: 71.73 (-0.89), UVV: 41.65 (-0.86)

Is Now the Time to Buy HCP, Inc.?
Chris Walczak, The Motley Fool - Motley Fool - Thu Dec 18, 10:55AM CST
If we could go back in time to 1985, HCP, Inc 's IPO would unquestionably be a stock to buy. The company, which manages and operates real estate in the health care field, is one of just three real estate investment trusts, or REITs, that are part...
HCP: 44.00 (-0.45), HCN: 76.10 (-0.58), OHI: 39.38 (-0.05), VTR: 71.73 (-0.89)

Ventas Has Returned 16.4% Since SmarTrend Recommendation (VTR)
Comtex SmarTrend(R) - Wed Dec 17, 5:05PM CST
SmarTrend identified an Uptrend for Ventas (NYSE:VTR) on October 7th, 2014 at $62.93. In approximately 2 months, Ventas has returned 16.39% as of today's recent price of $73.25.
VTR: 71.73 (-0.89)

SmarTrend Watching for Potential Rebound in Shares of Ventas After 1.00% Loss
Comtex SmarTrend(R) - Tue Dec 16, 5:40PM CST
Ventas (NYSE:VTR) traded in a range yesterday that spanned from a low of $71.94 to a high of $73.01. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $72.38 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTR: 71.73 (-0.89)

Watch for Ventas to Potentially Rebound After Falling 1.00% Yesterday
Comtex SmarTrend(R) - Tue Dec 16, 5:39PM CST
Ventas (NYSE:VTR) traded in a range yesterday that spanned from a low of $71.94 to a high of $73.01. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $72.38 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VTR: 71.73 (-0.89)

Ventas Moves Closer to American Realty Healthcare Merger - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 4:55PM CST
Ventas (VTR) moved a step closer to its merger with American Realty Capital Healthcare Trust (HCT), with the Securities and Exchange Commission (SEC) declaring the Form S-4 related to this merger as effective.
PSA: 187.43 (-1.18), PLD: 43.11 (-0.37), VTR: 71.73 (-0.89), HCT: 11.90 (-0.14)

American Realty Capital Healthcare Trust's pending merger agreement with Ventas declared effective by SEC
M2 - Tue Dec 16, 6:14AM CST
Ventas (NYSE:VTR) and American Realty Capital Healthcare Trust (NasdaqGS:HCT) on Monday jointly reported that the Securities and Exchange Commission ("SEC" has declared effective the registration statement on Form S-4, as amended, relating to the pending merge between the companies.
VTR: 71.73 (-0.89), HCT: 11.90 (-0.14)

Ventas Form S-4 in Connection with Its Pending Merger with American Realty Capital Healthcare Trust, Inc. Declared Effective by SEC
Business Wire - Mon Dec 15, 4:17PM CST
Ventas, Inc. (NYSE: VTR) ("Ventas" and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) ("HCT" today announced that the Securities and Exchange Commission ("SEC" has declared effective the registration statement on Form S-4, as amended, relating to the previously announced pending merger between Ventas and HCT pursuant to the Agreement and Plan of Merger, dated as of June 1, 2014, as amended (the "Merger Agreement" , by and among Ventas, HCT, Stripe Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of Ventas ("Merger Sub" , Stripe OP, LP, a Delaware limited partnership of which Merger Sub is the sole general partner, and American Realty Capital Healthcare Trust Operating Partnership L.P., a Delaware limited partnership.
VTR: 71.73 (-0.89), HCT: 11.90 (-0.14)

8 Stocks Taking Their Dividends Up A Notch
Dividends4Life - at Seeking Alpha - Fri Dec 12, 7:25PM CST

HASI: 14.11 (-0.15), AXS: 51.56 (-0.34), BMR: 21.76 (-0.15), GPT: 6.96 (+0.06), COR: 38.83 (+0.43), BMY: 59.15 (-0.01), VTR: 71.73 (-0.89), EIX: 66.75 (+1.41)

Stock Updates on Health Care REITs - HCP Inc., Ventas, American Realty Capital Healthcare Trust, Health Care REIT, and Medical Properties Trust
PR Newswire - Fri Dec 12, 7:35AM CST
Investor-Edge has initiated coverage on the following equities: HCP Inc. (NYSE: HCP), Ventas Inc. (NYSE: VTR), American Realty Capital Healthcare Trust Inc. (NASDAQ: HCT), Health Care REIT Inc. (NYSE: HCN), and Medical Properties Trust Inc. (NYSE: MPW). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, December 11, 2014, the NASDAQ Composite ended at 4,708.16, up 0.52%, the Dow Jones Industrial Average advanced 0.36%, to finish the day at 17,596.34, and the S&P 500 closed at 2,035.33, up 0.45%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Financials Sector Index ended the day at 330.84, up 0.33%, with the index also advancing 5.20% in the previous three months. Register for your complimentary reports on these five stocks at:
MPW: 13.70 (-0.05), HCP: 44.00 (-0.45), HCN: 76.10 (-0.58), VTR: 71.73 (-0.89), HCT: 11.90 (-0.14)

I Just Got Another Raise - Thanks Ventas, Inc.
Brad Thomas - at Seeking Alpha - Fri Dec 12, 6:00AM CST

VTR: 71.73 (-0.89), HCT: 11.90 (-0.14)

Dividend Growth Investing: How I Derive The Top 40 (Part 3)
David Van Knapp - at Seeking Alpha - Thu Dec 11, 8:42PM CST

KMI: 42.01 (+0.10), CLX: 105.46 (-0.62), MHLD: 12.98 (-0.09), ACN: 91.32 (-0.10), VTR: 71.73 (-0.89)

Ventas Declares 9% Sequential Hike in 4Q Cash Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 4:15PM CST
Ventas (VTR) announced a 9% sequential hike in its fourth-quarter 2014 dividend to 79 cents per share.
CXW: 37.94 (+0.05), CUZ: 11.55 (-0.03), AHT: 10.87 (-0.04), VTR: 71.73 (-0.89)

Ventas declares $0.79/share quarterly dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 5:38AM CST

VTR: 71.73 (-0.89)

Ventas' board reports 9% rise in Q4 2014 dividend
M2 - Thu Dec 11, 5:11AM CST
Ventas (NYSE:VTR), a real estate investment trust with a portfolio that includes medical office buildings, declared on Wednesday that its board of directors approved a dividend of USD0.79 per share of the company's stock for the fourth quarter of 2014.
VTR: 71.73 (-0.89)

Ventas Increases Fourth Quarter 2014 Dividend by Nine Percent
Business Wire - Wed Dec 10, 6:20PM CST
Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company" said today that its Board of Directors increased the Company's fourth quarter 2014 dividend by nine percent to $0.79 per share. The dividend is payable in cash on December 31, 2014 to stockholders of record on December 22, 2014. For the past ten years, the compound annual growth rate in the Company's dividend has been nine percent.
VTR: 71.73 (-0.89)

Ventas Up 16.8% Since SmarTrend Uptrend Call (VTR)
Comtex SmarTrend(R) - Wed Dec 10, 11:14AM CST
SmarTrend identified an Uptrend for Ventas (NYSE:VTR) on October 7th, 2014 at $62.94. In approximately 2 months, Ventas has returned 16.79% as of today's recent price of $73.50.
VTR: 71.73 (-0.89)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 147

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 114

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 19

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 139

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 72

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading

Top 5 Most Recently Viewed Articles

Trinseo Announces New Dividend Amid Strategic Changes Ahead

Updated Category News Views 225

Trinseo Approves Dividend for Shareholders Trinseo (NYSE: TSE), a prominent provider of specialty material solutions, has recently announced a quarterly dividend approved by its Board of Directors. The dividend declared stands at $0.01 per share, set to be distributed on a future date, offering a slight financial incentive for shareholders. To be eligible, shareholders...

Continue Reading
2026 Mighty 25: Celebrating Military Community Leaders

Updated Category News Views 26

A Spotlight on Unsung Heroes Tampa, Florida, just got a little mightier as We Are The Mighty rolls out the red carpet for the 2026 Mighty 25. This annual roll call, backed by CareSource Military & Veterans™, shines a light on veterans, military spouses, creators, entrepreneurs, and change agents defying the status quo. They are redefining impact across the military...

Continue Reading
Rubrik Inc Soars as Earnings Beat Expectations

Updated Category News Views 238

Rubrik Inc's Recent Stock Surge Rubrik, Inc. (NYSE: RBRK) has recently captured the attention of the market as its shares have risen over 20% following an impressive report of fourth-quarter earnings. The company exceeded expectations in both profitability and revenue, which undoubtedly prompted a wave of investor optimism. Financial Performance Highlights For the latest...

Continue Reading
Sanofi’s Amlitelimab Achieves Key Study Goals for Eczema Treatment

Updated Category News Views 284

Sanofi’s Amlitelimab Revolutionizes Atopic Dermatitis Treatment In an exciting development for patients suffering from atopic dermatitis, Sanofi's amlitelimab has met all primary and key secondary endpoints in the pivotal COAST 1 phase 3 study, targeting both adults and adolescents. This innovative medication demonstrated meaningful efficacy in terms of skin clearance...

Continue Reading
Alphamin Resources Corp: Board Changes and Future Outlook

Updated Category News Views 168

Leadership Changes at Alphamin Resources Corp Alphamin Resources Corp., a prominent player in the mining sector, recently shared significant news regarding its board of directors. The company announced the resignation of Mr. Rudolf Pretorius as a director. This change marks a pivotal moment in the company’s leadership structure, as Mr. Pretorius had been with the board...

Continue Reading